Global PD-L1 Biomarker Testing Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of PD-L1 Biomarker Testing will have significant change from previous year. According to our latest study, the global PD-L1 Biomarker Testing market size is USD million in 2022 from USD 1438.5 million in 2021, with a change of % between 2021 and 2022. The global PD-L1 Biomarker Testing market size will reach USD 15280 million in 2028, growing at a CAGR of 40.1% over the analysis period.
The United States PD-L1 Biomarker Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global PD-L1 Biomarker Testing market, reaching US$ million by the year 2028. As for the Europe PD-L1 Biomarker Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main PD-L1 Biomarker Testing players cover Agilent Technologies, Roche, Merck, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-L1 Biomarker Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Diagnostic Center
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size 2017-2028
2.1.2 PD-L1 Biomarker Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 PD-L1 Biomarker Testing Segment by Type
2.2.1 PD-L1 (22C3)
2.2.2 PD-L1(28-8)
2.2.3 PD-L1 (SP142)
2.2.4 PD-L1 (SP263)
2.2.5 Other
2.3 PD-L1 Biomarker Testing Market Size by Type
2.3.1 PD-L1 Biomarker Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2022)
2.4 PD-L1 Biomarker Testing Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 PD-L1 Biomarker Testing Market Size by Application
2.5.1 PD-L1 Biomarker Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2022)
3 PD-L1 Biomarker Testing Market Size by Player
3.1 PD-L1 Biomarker Testing Market Size Market Share by Players
3.1.1 Global PD-L1 Biomarker Testing Revenue by Players (2020-2022)
3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2020-2022)
3.2 Global PD-L1 Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PD-L1 Biomarker Testing by Regions
4.1 PD-L1 Biomarker Testing Market Size by Regions (2017-2022)
4.2 Americas PD-L1 Biomarker Testing Market Size Growth (2017-2022)
4.3 APAC PD-L1 Biomarker Testing Market Size Growth (2017-2022)
4.4 Europe PD-L1 Biomarker Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa PD-L1 Biomarker Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas PD-L1 Biomarker Testing Market Size by Country (2017-2022)
5.2 Americas PD-L1 Biomarker Testing Market Size by Type (2017-2022)
5.3 Americas PD-L1 Biomarker Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PD-L1 Biomarker Testing Market Size by Region (2017-2022)
6.2 APAC PD-L1 Biomarker Testing Market Size by Type (2017-2022)
6.3 APAC PD-L1 Biomarker Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe PD-L1 Biomarker Testing by Country (2017-2022)
7.2 Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022)
7.3 Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa PD-L1 Biomarker Testing by Region (2017-2022)
8.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global PD-L1 Biomarker Testing Market Forecast
10.1 Global PD-L1 Biomarker Testing Forecast by Regions (2023-2028)
10.1.1 Global PD-L1 Biomarker Testing Forecast by Regions (2023-2028)
10.1.2 Americas PD-L1 Biomarker Testing Forecast
10.1.3 APAC PD-L1 Biomarker Testing Forecast
10.1.4 Europe PD-L1 Biomarker Testing Forecast
10.1.5 Middle East & Africa PD-L1 Biomarker Testing Forecast
10.2 Americas PD-L1 Biomarker Testing Forecast by Country (2023-2028)
10.2.1 United States PD-L1 Biomarker Testing Market Forecast
10.2.2 Canada PD-L1 Biomarker Testing Market Forecast
10.2.3 Mexico PD-L1 Biomarker Testing Market Forecast
10.2.4 Brazil PD-L1 Biomarker Testing Market Forecast
10.3 APAC PD-L1 Biomarker Testing Forecast by Region (2023-2028)
10.3.1 China PD-L1 Biomarker Testing Market Forecast
10.3.2 Japan PD-L1 Biomarker Testing Market Forecast
10.3.3 Korea PD-L1 Biomarker Testing Market Forecast
10.3.4 Southeast Asia PD-L1 Biomarker Testing Market Forecast
10.3.5 India PD-L1 Biomarker Testing Market Forecast
10.3.6 Australia PD-L1 Biomarker Testing Market Forecast
10.4 Europe PD-L1 Biomarker Testing Forecast by Country (2023-2028)
10.4.1 Germany PD-L1 Biomarker Testing Market Forecast
10.4.2 France PD-L1 Biomarker Testing Market Forecast
10.4.3 UK PD-L1 Biomarker Testing Market Forecast
10.4.4 Italy PD-L1 Biomarker Testing Market Forecast
10.4.5 Russia PD-L1 Biomarker Testing Market Forecast
10.5 Middle East & Africa PD-L1 Biomarker Testing Forecast by Region (2023-2028)
10.5.1 Egypt PD-L1 Biomarker Testing Market Forecast
10.5.2 South Africa PD-L1 Biomarker Testing Market Forecast
10.5.3 Israel PD-L1 Biomarker Testing Market Forecast
10.5.4 Turkey PD-L1 Biomarker Testing Market Forecast
10.5.5 GCC Countries PD-L1 Biomarker Testing Market Forecast
10.6 Global PD-L1 Biomarker Testing Forecast by Type (2023-2028)
10.7 Global PD-L1 Biomarker Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Offered
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche PD-L1 Biomarker Testing Product Offered
11.2.3 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck PD-L1 Biomarker Testing Product Offered
11.3.3 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck Main Business Overview
11.3.5 Merck Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Offered
11.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca PD-L1 Biomarker Testing Product Offered
11.5.3 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Ono Pharmaceutical
11.6.1 Ono Pharmaceutical Company Information
11.6.2 Ono Pharmaceutical PD-L1 Biomarker Testing Product Offered
11.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Ono Pharmaceutical Main Business Overview
11.6.5 Ono Pharmaceutical Latest Developments
11.7 Regeneron
11.7.1 Regeneron Company Information
11.7.2 Regeneron PD-L1 Biomarker Testing Product Offered
11.7.3 Regeneron PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Regeneron Main Business Overview
11.7.5 Regeneron Latest Developments
11.8 Innovent
11.8.1 Innovent Company Information
11.8.2 Innovent PD-L1 Biomarker Testing Product Offered
11.8.3 Innovent PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Innovent Main Business Overview
11.8.5 Innovent Latest Developments
11.9 Hengrui Medicine
11.9.1 Hengrui Medicine Company Information
11.9.2 Hengrui Medicine PD-L1 Biomarker Testing Product Offered
11.9.3 Hengrui Medicine PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hengrui Medicine Main Business Overview
11.9.5 Hengrui Medicine Latest Developments
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Information
11.10.2 Junshi Biosciences PD-L1 Biomarker Testing Product Offered
11.10.3 Junshi Biosciences PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Junshi Biosciences Main Business Overview
11.10.5 Junshi Biosciences Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. PD-L1 Biomarker Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of PD-L1 (22C3)
Table 3. Major Players of PD-L1(28-8)
Table 4. Major Players of PD-L1 (SP142)
Table 5. Major Players of PD-L1 (SP263)
Table 6. Major Players of Other
Table 7. PD-L1 Biomarker Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global PD-L1 Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 10. PD-L1 Biomarker Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global PD-L1 Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 13. Global PD-L1 Biomarker Testing Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global PD-L1 Biomarker Testing Revenue Market Share by Player (2020-2022)
Table 15. PD-L1 Biomarker Testing Key Players Head office and Products Offered
Table 16. PD-L1 Biomarker Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global PD-L1 Biomarker Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global PD-L1 Biomarker Testing Market Size Market Share by Regions (2017-2022)
Table 21. Americas PD-L1 Biomarker Testing Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas PD-L1 Biomarker Testing Market Size Market Share by Country (2017-2022)
Table 23. Americas PD-L1 Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 25. Americas PD-L1 Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 27. APAC PD-L1 Biomarker Testing Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC PD-L1 Biomarker Testing Market Size Market Share by Region (2017-2022)
Table 29. APAC PD-L1 Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 31. APAC PD-L1 Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 33. Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe PD-L1 Biomarker Testing Market Size Market Share by Country (2017-2022)
Table 35. Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 37. Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa PD-L1 Biomarker Testing Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of PD-L1 Biomarker Testing
Table 46. Key Market Challenges & Risks of PD-L1 Biomarker Testing
Table 47. Key Industry Trends of PD-L1 Biomarker Testing
Table 48. Global PD-L1 Biomarker Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global PD-L1 Biomarker Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global PD-L1 Biomarker Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global PD-L1 Biomarker Testing Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global PD-L1 Biomarker Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global PD-L1 Biomarker Testing Market Size Market Share Forecast by Application (2023-2028)
Table 54. Agilent Technologies Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 55. Agilent Technologies PD-L1 Biomarker Testing Product Offered
Table 56. Agilent Technologies PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Agilent Technologies Main Business
Table 58. Agilent Technologies Latest Developments
Table 59. Roche Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 60. Roche PD-L1 Biomarker Testing Product Offered
Table 61. Roche Main Business
Table 62. Roche PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Roche Latest Developments
Table 64. Merck Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 65. Merck PD-L1 Biomarker Testing Product Offered
Table 66. Merck Main Business
Table 67. Merck PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Merck Latest Developments
Table 69. Bristol-Myers Squibb Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 70. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Offered
Table 71. Bristol-Myers Squibb Main Business
Table 72. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Bristol-Myers Squibb Latest Developments
Table 74. AstraZeneca Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 75. AstraZeneca PD-L1 Biomarker Testing Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. AstraZeneca Latest Developments
Table 79. Ono Pharmaceutical Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 80. Ono Pharmaceutical PD-L1 Biomarker Testing Product Offered
Table 81. Ono Pharmaceutical Main Business
Table 82. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Ono Pharmaceutical Latest Developments
Table 84. Regeneron Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 85. Regeneron PD-L1 Biomarker Testing Product Offered
Table 86. Regeneron Main Business
Table 87. Regeneron PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Regeneron Latest Developments
Table 89. Innovent Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 90. Innovent PD-L1 Biomarker Testing Product Offered
Table 91. Innovent Main Business
Table 92. Innovent PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Innovent Latest Developments
Table 94. Hengrui Medicine Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 95. Hengrui Medicine PD-L1 Biomarker Testing Product Offered
Table 96. Hengrui Medicine Main Business
Table 97. Hengrui Medicine PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Hengrui Medicine Latest Developments
Table 99. Junshi Biosciences Details, Company Type, PD-L1 Biomarker Testing Area Served and Its Competitors
Table 100. Junshi Biosciences PD-L1 Biomarker Testing Product Offered
Table 101. Junshi Biosciences Main Business
Table 102. Junshi Biosciences PD-L1 Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Junshi Biosciences Latest Developments
List of Figures
Figure 1. PD-L1 Biomarker Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PD-L1 Biomarker Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global PD-L1 Biomarker Testing Market Size Market Share by Type in 2021
Figure 7. PD-L1 Biomarker Testing in Hospital
Figure 8. Global PD-L1 Biomarker Testing Market: Hospital (2017-2022) & ($ Millions)
Figure 9. PD-L1 Biomarker Testing in Diagnostic Center
Figure 10. Global PD-L1 Biomarker Testing Market: Diagnostic Center (2017-2022) & ($ Millions)
Figure 11. PD-L1 Biomarker Testing in Others
Figure 12. Global PD-L1 Biomarker Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global PD-L1 Biomarker Testing Market Size Market Share by Application in 2021
Figure 14. Global PD-L1 Biomarker Testing Revenue Market Share by Player in 2021
Figure 15. Global PD-L1 Biomarker Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas PD-L1 Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC PD-L1 Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe PD-L1 Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa PD-L1 Biomarker Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas PD-L1 Biomarker Testing Value Market Share by Country in 2021
Figure 21. Americas PD-L1 Biomarker Testing Consumption Market Share by Type in 2021
Figure 22. Americas PD-L1 Biomarker Testing Market Size Market Share by Application in 2021
Figure 23. United States PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC PD-L1 Biomarker Testing Market Size Market Share by Region in 2021
Figure 28. APAC PD-L1 Biomarker Testing Market Size Market Share by Application in 2021
Figure 29. China PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe PD-L1 Biomarker Testing Market Size Market Share by Country in 2021
Figure 36. Europe PD-L1 Biomarker Testing Market Size Market Share by Type in 2021
Figure 37. Europe PD-L1 Biomarker Testing Market Size Market Share by Application in 2021
Figure 38. Germany PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Application in 2021
Figure 46. Egypt PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country PD-L1 Biomarker Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 59. China PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 63. India PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 66. France PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries PD-L1 Biomarker Testing Market Size 2023-2028 ($ Millions)